Hims & Hers Stock Plummets Despite Major Share Repurchase Initiative

The telehealth company Hims & Hers Health has seen its share price collapse by 30% over the past month, a stark contrast to the confidence it aimed to project with the announcement of a substantial $250 million stock buyback program. This dramatic sell-off coincides with insider stock sales and occurs while the company’s valuation appears stretched to unprecedented levels, raising significant questions about its current market position.

A primary concern for market participants is the company’s valuation. Hims & Hers shares are currently trading at a price-to-earnings (P/E) ratio ranging from 61 to 66. This figure stands in sharp relief against the healthcare sector’s average P/E of just 21.9. Even when measured Read more...